These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29374419)

  • 1. Implantable cardioverter defibrillator does not cure the heart.
    Sławuta A; Boczar K; Ząbek A; Gajek J; Lelakowski J; Vijayaraman P; Małecka B
    Pol Merkur Lekarski; 2018 Jan; 44(259):23-25. PubMed ID: 29374419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal management of patient with permanent atrial fibrillation and heart failure with reduced ejection fraction - The permanent His-bundle pacing is a solution. A case report.
    Skonieczny B; Gajek A; Strózik P; Zawadzki J; Adamowicz J; Gajek J; Sławuta A
    J Electrocardiol; 2018; 51(6):1141-1144. PubMed ID: 30497746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy.
    Wang S; Wu S; Xu L; Xiao F; Whinnett ZI; Vijayaraman P; Su L; Huang W
    J Am Heart Assoc; 2019 Dec; 8(24):e014253. PubMed ID: 31830874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual chamber cardioverter-defibrillator used for His bundle pacing in patient with chronic atrial fibrillation.
    Sławuta A; Biały D; Moszczyńska-Stulin J; Berkowski P; Dąbrowski P; Gajek J
    Int J Cardiol; 2015 Mar; 182():395-8. PubMed ID: 25617606
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of right ventricular bifocal pacing in patients with permanent atrial fibrillation and severe dilated cardiomiopathy due to Chagas disease: three years of follow-up.
    da Silva Menezes A
    J Interv Card Electrophysiol; 2004 Dec; 11(3):193-8. PubMed ID: 15548885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death].
    Pudło J; Liszniański P; Senderek T; Lelakowska-Pieła M; Lelakowski J; Nowak J
    Pol Merkur Lekarski; 2015 Aug; 39(230):86-90. PubMed ID: 26319381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction.
    Huang W; Su L; Wu S; Xu L; Xiao F; Zhou X; Ellenbogen KA
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of ventricular tachycardia/fibrillation to beta-blocker dose maximization guided by pacing mode analysis in nonpacemaker-dependent patients with implantable cardioverter-defibrillator.
    Deftereos S; Giannopoulos G; Kossyvakis C; Kaoukis A; Raisakis K; Panagopoulou V; Ntzouvara O; Perpinia A; Rentoukas I; Pyrgakis V; Manolis AS; Stefanadis C
    Am J Cardiol; 2011 Jun; 107(12):1812-7. PubMed ID: 21481829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct His-Bundle Pacing Improved Left Ventricular Function and Remodelling in a Biventricular Pacing Nonresponder.
    Shan P; Su L; Chen X; Xu L; Ni X; Huang W
    Can J Cardiol; 2016 Dec; 32(12):1577.e1-1577.e4. PubMed ID: 26899255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pacing and sensing optimization of permanent His-bundle pacing in cardiac resynchronization therapy/implantable cardioverter defibrillators patients: value of integrated bipolar configuration.
    Su L; Xu L; Wu SJ; Huang WJ
    Europace; 2016 Sep; 18(9):1399-405. PubMed ID: 26581403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. His-bundle pacing using dual-chamber cardioverter-defibrillator in patients with chronic atrial fibrillation: different pacing and sensing features.
    Sławuta A; Biały D; Zyśko D; Mazur G; Gajek J
    Acta Cardiol; 2017 Jun; 72(3):343-344. PubMed ID: 28636524
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical utility of direct His-bundle pacing in patients with heart failure and permanent atrial fibrillation.
    Ciesielski A; Boczar K; Siekiera M; Gajek J; Sławuta A
    Acta Cardiol; 2022 Apr; 77(2):114-121. PubMed ID: 34006173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of rate-adaptive pacing in patients implanted with implantable cardioverter-defibrillator and subsequent differential clinical outcomes.
    Källner N; Nishimura M; Birgersdotter-Green U; Hoffmayer KS; Han FT; Krummen DE; Raissi F; Feld GK; Hsu JC
    J Interv Card Electrophysiol; 2019 Jun; 55(1):83-91. PubMed ID: 30929121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
    Kosiuk J; Nedios S; Darma A; Rolf S; Richter S; Arya A; Piorkowski C; Gaspar T; Sommer P; Husser D; Hindricks G; Bollmann A
    Europace; 2014 Sep; 16(9):1322-6. PubMed ID: 24532559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
    Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.